The data from these patients are compatible with the view that one factor in the control of renin production by the kidney is the attenuation of the blood pressure by the afferent arteriole. The cardiovascular reflexes are abnormal in patients with postural hypotension. The evidence suggests that the renal vessels have diminished tone. The pressure at the juxtaglomerular cells, where renin is formed, will move in parallel with the blood pressure. When the patient is lying down, the pressure acting on the juxtaglomerular cells will suppress renin. Even on standing it is probable that the fall in blood pressure is insufficient to stimulate renin production to a normal level because of the lack of renal vascular tone. The diminished renin production leads to the low aldosterone production rate. In the patient with hypopituitarism and diabetes the absence of ACTH would be expected to lower the aldosterone still further.
The excretion of sodium by the kidney is regulated by a pressure-sensitive mechanism in the kidney (Mills 1965 , de Bono & Mills 1965 , Mills 1968 . The experiments of de Bono & Mills (1965) indicate that the site is distal to the afferent arteriole and may be in the region of the juxtaglomerular apparatus. With loss of neural control of renal arteriolar tone the pressure at this site will vary with the blood pressure.
In patients with postural hypotension the blood pressure rises when they lie down. As this pressure is transmitted to the pressure-sensitive site, owing to the lack of nervous tone, the kidney is stimulated to excrete sodium. The reverse occurs on standing up. When they sleep in a bed tilted at 14 degrees there is a tendency for pooling of blood in the dependent parts and the blood pressure tends to fall. Consequently the kidneys are stimulated to retain sodium; this is potentiated by small amounts of fludrocortisone. When the patient was on a tilted bed fludrocortisone caused sodium retention with little potassium loss. In the patient who was on a horizontal bed and given a larger dose of fludrocortisone potassium loss occurred immediately and led to hypokalemia. It is probable from these facts that bed-tilting stimulates sodium retention in the proximal tubule. As a result sodium reaching the distal tubule, where exchange with potassium is increased by fludrocortisone, is insufficient to cause potassium wastage.
Hypertension and Hyperaldosteronism with Low Plasma Renin Concentration: Analysis ofa Series ofEighty-two Patients This paper is concerned with a series of 82 patients, all of whom had aldosterone excess and subnormal or low plasma renin concentration.
Hyperaldosteronism of this kind is often referred to as 'primary', although the term is not satisfactory. It should be emphasized that the combination of low renin with increased aldosterone is to be expected in any case in which aldosterone secretion is stimulated other than by the renin-angiotensin system (Brown, Davies, Lever, Peart & Robertson 1964) .
Methods
Aldosterone secretion rate was estimated either by the method of Cope et al. (1961) , or by that of Brooks (1960) and plasma aldosterone concentration by the method of . Renin was measured by the method of Brown, Davies, Lever, Robertson & Tree (1964) . Total exchangeable sodium (NaB) and potassium (KB), total body water (TBW), extracellular fluid volume (ECF) and plasma volume were estimated by isotope dilution as described previously (Brown et al. 1965 , Brown, Fraser, James, Lever, McCusker, Robertson & Wynn 1968 ). Blood samples were taken from a peripheral vein of recumbent patients consuming a normal diet. In the majority, studies were carried out in a metabolic ward while daily intake was held constant at a point between 120 and 140 mEq Na and between 40 and 70 mEq K. All inpatients' samples were taken between 9 and 10 a.m., before the subject rose. Diuretics had not been received by any patient for at least one month before the period of study.
Results
Aldosterone: In the majority of the present patients (72), the diagnosis of hyperaldosteronism was made by demonstrating an increased plasma aldosterone concentration, the upper limit of normal being 18 ng/100 ml. The method of measurement used ) had the following performance characteristics over a period of one year (January-December 1968). Replicate estimations from a stock plasma pool had a mean value of 13-06 ng/100 ml, and an overall range of 12-03 to 13-98 ng/100 ml (n=22). During the same period the gross blank, containing 11 ng/100 ml of added 14C-aldosterone, had a mean value of 11P21 ng/100 ml, and a range of 9 07 to 12-08 ng/100 ml (n=24). In the patients, levels ranging from 19 to 425 ng/100 ml were recorded.
In 10 subjects increased aldosterone secretion rates were found (range 230-2,500 ,ug/24 hours).
Plasma renin concentration: Peripheral venous plasma renin concentration has a normal range of 4 to 20 units/I, mean 8-4 units/l (Brown, Davies, Lever, Robertson & Tree 1964) . With this method replicate estimations over the period 1967-68 from a stock plasma pool had a mean value of 24-97 units/l (SD +398 units/l, n =62).
It is to be noted that serial dilutions of the renin-containing plasma extract gave reaction velocities which paralleled those of serial dilutions of renin prepared from human kidneys (Fig 1) . This observation is important in view of the contrary finding of Skinner (1967), using a somewhat different technique. He obtained divergent sets of reaction velocities when serial dilutions of renal and plasma extracts were compared. In the present series of patients with hyperaldosteronism, plasma renin concentration was below the normal mean in all, below the normal lower limit in 60, and undetectable in 2.
Relationship Between Plasma Renin and Plasma Aldosterone Concentration
There was a significant, although not particularly close, inverse relationship between plasma renin and plasma aldosterone concentration (r= -0'266, n=70, P<0-05) (Fig 2) . This contrasts with a much closer positive correlation found in a small group of hypertensive patients with secondary hyperaldosteronism due to a renal lesion and/or the malignant phase. In these, renin, as well as aldosterone, was abnormally high (r= +0 790, n=7, P<0 02) (Fig 2) .
Potassium
Plasma was used in preference to serum for potassium estimation, since we and others (see Brown, Chinn, Davies, Diisterdieck, Fraser, Lever, Robertson, Tree & Wiseman 1968) have found that, concurrently estimated on the same blood sample, potassium is consistently higher in serum than in plasma, although by a variable extent. The normal range for plasma potassium in this laboratory is 3 7-5 2 mEq/l, mean 4 12 (n=36). It is important, during venepuncture, to avoid forearm exercise, since this will cause substantial increases in plasma potassium, and has been shown to obscure significant hypokaltemia in patients with hyperaldosteronism.
Plasma potassium, estimated on 762 occasions in the 82 patients with hyperaldosteronism and low renin, was found to be persistently below 3-7 mEq/l in 37 patients (284 estimations), while 35 subjects showed only intermittent hypokalmmia (279 of 418 estimations), and 10 patients no hypokalemia (60 estimations). This was a highly selected series of patients, but repeated estimations clearly offer a greater chance of detecting hypokalemia.
Adrenal Histology
Adrenal exploration had been carried out in 54 patients at the time of writing. The findings were: i~ single adenoma 36; adenoma plus micronodular hyperplasia 5; micronodular hyperplasia 8; hyperplastic zona glomerulosa 3; no histological abnormality detected 2.
Surgical Results
Forty-three patients had been followed for six or more months after operation. Taking a diastolic pressure of 100 mmHg or less at least six months after operation as 'successful', there were, in relation to adrenal histology: adenoma alone 28 successes, 2 failures; adenoma plus micronodular hyperplasia 1 success, 3 failures; micronodular hyperplasia 3 successes, 1 failure; hyperplastic zona glomerulosa 3 failures; no histological abnormality 2 failures.
One patient died from postoperative intraperitoneal hemorrhage, and another who sustained a myocardial infarction on the day after operation eventually died three months later without leaving hospital.
Treatment with Spironolactone Forty-one patients received a prolonged course of spironolactone (150-400 mg/day) by mouth before adrenal surgery (see Brown, Davies, Lever, Peart & Robertson 1964 , Brown et al. 1965 . In all instances this corrected hypokalkmia where present. In 37, satisfactory lowering of the blood pressure was also achieved. Thirteen patients have not yet undergone adrenal surgery, and are currently maintained on spironolactone with good control of blood pressure, in one case since 1963.
Side-effects of spironolactone, apart from breast engorgement in the male, and two complaints of impotence, were minor. Dyspepsia can be reduced by taking the drug after meals; one case of gastric ulcer occurred, but could well have been coincidental. Other side-effects have included constipation, dysmenorrhcea and excessive sweating.
Comparison ofSpironolactone with Adrenal Surgery
In 21 patients a prolonged course of spironolactone was followed by successful adrenal surgery. The degree of blood pressure lowering produced by surgery was very similar to that achieved by previous spironolactone.
Both forms of treatment were associated with a similar increase in plasma potassium and KE, and a comparable fall in body weight, plasma sodium, NaE, TBW, plasma volume and ECF. Both forms of treatment increased plasma renin concentration, and occasional abnormally high renin levels were found during spironolactone therapy.
Plasma aldosterone fell to normal after surgery.
In 3 patients, the arterial pressure was unaffected either by spironolactone or by subsequent surgery, although the plasma aldosterone was normal following adrenalectomy. Similar persistent hypertension after correction of a supposedly causative lesion has been encountered in other situations (Pickering 1968 ). Three patients showed a good response to spironolactone, but subsequent adrenalectomy failed to control the hypertension. It appeared likely that, in these, adrenal surgery had been insufficiently extensive. Reintroduction of spironolactone in 2 of the 3 corrected the hypertension.
